Correlation Between AN2 Therapeutics and Adagene
Can any of the company-specific risk be diversified away by investing in both AN2 Therapeutics and Adagene at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining AN2 Therapeutics and Adagene into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between AN2 Therapeutics and Adagene, you can compare the effects of market volatilities on AN2 Therapeutics and Adagene and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in AN2 Therapeutics with a short position of Adagene. Check out your portfolio center. Please also check ongoing floating volatility patterns of AN2 Therapeutics and Adagene.
Diversification Opportunities for AN2 Therapeutics and Adagene
-0.54 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between AN2 and Adagene is -0.54. Overlapping area represents the amount of risk that can be diversified away by holding AN2 Therapeutics and Adagene in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Adagene and AN2 Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on AN2 Therapeutics are associated (or correlated) with Adagene. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Adagene has no effect on the direction of AN2 Therapeutics i.e., AN2 Therapeutics and Adagene go up and down completely randomly.
Pair Corralation between AN2 Therapeutics and Adagene
Given the investment horizon of 90 days AN2 Therapeutics is expected to generate 0.97 times more return on investment than Adagene. However, AN2 Therapeutics is 1.03 times less risky than Adagene. It trades about 0.02 of its potential returns per unit of risk. Adagene is currently generating about -0.11 per unit of risk. If you would invest 127.00 in AN2 Therapeutics on October 20, 2024 and sell it today you would earn a total of 0.00 from holding AN2 Therapeutics or generate 0.0% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 95.0% |
| Values | Daily Returns |
AN2 Therapeutics vs. Adagene
Performance |
| Timeline |
| AN2 Therapeutics |
| Adagene |
AN2 Therapeutics and Adagene Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with AN2 Therapeutics and Adagene
The main advantage of trading using opposite AN2 Therapeutics and Adagene positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if AN2 Therapeutics position performs unexpectedly, Adagene can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Adagene will offset losses from the drop in Adagene's long position.| AN2 Therapeutics vs. Aerovate Therapeutics | AN2 Therapeutics vs. Adagene | AN2 Therapeutics vs. Acrivon Therapeutics, Common | AN2 Therapeutics vs. Rezolute |
| Adagene vs. Aerovate Therapeutics | Adagene vs. Acrivon Therapeutics, Common | Adagene vs. Rezolute | Adagene vs. AN2 Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.
Other Complementary Tools
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated |